SCHEMBL20566017

SCHEMBL20566017

CC(C)(C)OC(=O)NCC(Cn1cc(-c2ccc(OCC(O)C(=O)O)cc2F)cn1)NC(=O)OC(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 1/20 0.36
▸ AAK1 Q2M2I8 5/20 0.36
▸ ALOX5AP P20292 2/20 0.35
▸ FEN1 P39748 2/20 0.35
▸ SYK P43405 1/20 0.35
▸ S1PR3 Q99500 1/20 0.33
▸ SCN9A Q15858 1/20 0.32
▸ FAAH O00519 1/20 0.32
▸ PDK2 Q15119 1/20 0.32
▸ CTSS P25774 1/20 0.31
▸ CTSK P43235 1/20 0.31
▸ FFAR1 O14842 1/20 0.31
▸ ACACB O00763 1/20 0.31
▸ ACACA Q13085 1/20 0.31
▸ IRAK1 P51617 1/20 0.31
▸ TBK1 Q9UHD2 1/20 0.31
▸ HDAC3 O15379 1/20 0.31
▸ HDAC4 P56524 1/20 0.31
▸ HDAC1 Q13547 1/20 0.31
▸ HDAC7 Q8WUI4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18991385 1.00 PTPN1 (0.36) PTPN1AAK1ALOX5APFEN1SYK
SCHEMBL29356435 0.89 SYK (0.36) PTPN1AAK1ALOX5APFEN1SYK
SCHEMBL18991650 0.86 ALOX5AP (0.33) PTPN1ALOX5APFEN1SCN9AFAAH
SCHEMBL20565913 0.86 ALOX5AP (0.33) PTPN1ALOX5APFEN1SCN9AFAAH
SCHEMBL18991109 0.85 ALOX5AP (0.41) ALOX5APFEN1SCN9AFAAHPDK2
SCHEMBL18991107 0.85 ALOX5AP (0.41) ALOX5APFEN1SCN9AFAAHPDK2
SCHEMBL20566946 0.79 AR (0.36) CTSSCTSK
SCHEMBL18991854 0.79 AR (0.36) CTSSCTSK
SCHEMBL29357839 0.78 FEN1 (0.41) ALOX5APFEN1SCN9AFAAHPDK2
SCHEMBL29357870 0.77 ALOX5AP (0.33) PTPN1ALOX5APFEN1S1PR3SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11230543-B2 Biaryl monobactam compounds and methods of use thereof for the treatment of bacterial infections MERCK SHARP & DOHME CORP. (US) 2022-01-25 — — US disclosed
EP-3390357-B1 BIARYL MONOBACTAM COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS MERCK SHARP & DOHME (US) 2021-11-10 — — EP disclosed
US-20200361928-A1 BIARYL MONOBACTAM COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF BACTERIAL INFECTIONS MERCK SHARP & DOHME CORP. (US) 2020-11-19 — — US disclosed
US-20180339983-A1 BIARYL MONOBACTAM COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF BACTERIAL INFECTIONS MERCK SHARP & DOHME CORP. (US) 2018-11-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180339983-A1 BIARYL MONOBACTAM COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF BACTERIAL INFECTIONS BMX, BTK, ABCB11 PTPN1 1409/4885AAK1 3204/4885ALOX5AP 1416/4885
US-11230543-B2 Biaryl monobactam compounds and methods of use thereof for the treatment of bacterial infections SQLE, ABCB11, BMX PTPN1 1957/4885AAK1 2959/4885ALOX5AP 1208/4885
US-20200361928-A1 BIARYL MONOBACTAM COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF BACTERIAL INFECTIONS ABCB11, SQLE, BMX PTPN1 1953/4885AAK1 2994/4885ALOX5AP 1249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback